CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
3.130
+0.360 (13.00%)
At close: May 3, 2024, 4:00 PM
3.140
+0.010 (0.32%)
After-hours: May 3, 2024, 7:23 PM EDT

CureVac Revenue

In the year 2023, CureVac had annual revenue of $59.73M, a decrease of -16.72%. Revenue in the quarter ending December 31, 2023 was $25.07M with 101.64% year-over-year growth.

Revenue (ttm)
$59.73M
Revenue Growth
-16.72%
P/S Ratio
11.73
Revenue / Employee
$66,074
Employees
904
Market Cap
700.75M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202359.73M-11.99M-16.72%
Dec 31, 202271.72M-45.31M-38.72%
Dec 31, 2021117.03M57.44M96.37%
Dec 31, 202059.60M40.03M204.56%
Dec 31, 201919.57M4.77M32.27%
Dec 31, 201814.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novavax 983.71M
Phibro Animal Health 982.01M
Pharming Group 272.57M
Treace Medical Concepts 187.12M
AnaptysBio 17.16M
Autolus Therapeutics 1.70M
Revenue Rankings